tiprankstipranks
Traws Pharma (TRAW)
NASDAQ:TRAW
US Market
TRAW
Traws Pharma
RESEARCH TOOLSreports
Want to see TRAW full AI Analyst Report?

Traws Pharma (TRAW) Financial Statements

1,858 Followers

Traws Pharma Financial Overview

Traws Pharma's market cap is currently $11.58M. The company's EPS TTM is $-0.82; its P/E ratio is 1.01; Traws Pharma is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 2.79M$ 226.00K$ 226.00K$ 226.00K$ 226.00K
Gross Profit$ 2.73M$ 214.00K$ 226.00K$ 226.00K$ 226.00K
Operating Income$ -17.88M$ -49.35M$ -20.30M$ -19.63M$ -16.50M
EBITDA$ -17.81M$ -166.51M$ -20.28M$ -19.61M$ -16.48M
Net Income$ 9.17M$ -54.67M$ -18.95M$ -18.96M$ -16.16M
Balance Sheet
Cash & Short-Term Investments$ 3.82M$ 21.34M$ 20.82M$ 38.76M$ 55.07M
Total Assets$ 10.62M$ 24.96M$ 22.68M$ 39.37M$ 55.48M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.82M$ -21.34M$ -20.82M$ -38.76M$ -55.07M
Total Liabilities$ 11.25M$ 56.59M$ 12.01M$ 11.06M$ 9.36M
Stockholders' Equity$ -629.00K$ -31.63M$ 10.67M$ 28.31M$ 46.12M
Cash Flow
Free Cash Flow$ -20.77M$ -29.79M$ -17.95M$ -16.29M$ -19.49M
Operating Cash Flow$ -18.18M$ -29.79M$ -17.93M$ -16.29M$ -19.49M
Investing Cash Flow$ -2.58M$ -3.65M$ -14.00K$ 0.00$ 0.00
Financing Cash Flow$ 3.20M$ 33.98M$ 0.00$ 0.00$ 55.56M
Currency in USD

Traws Pharma Earnings and Revenue History

Income Statement >

Traws Pharma Debt to Assets

Balance Sheet >

Traws Pharma Cash Flow

Cash Flow >

Traws Pharma Forecast EPS vs Actual EPS

Earnings >